This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

epidemiology

JIA is the most common cause of chronic arthritis in childhood and a leading cause of short- and long-term disability .

  • between 0.07-4.01 per 1000 children are thought to be affected worldwide (1,2)

Incidence of the disease is estimated to be between 1-22 in 100,000 and a disease prevalence of 7-150 in 100,000

  • a study from Turkey reported a prevalence of chronic arthritis in childhood of 64 in 100,000 while a study from Australia showed a prevalence as high as 400 in 100,000 (1)

Frequency of JIA subtypes varies according to geographical areas or ethnic groups:

  • oligoarthritis is the most common subtype in Western countries
  • polyarthritis predominates in Costa Rica, India, New Zealand, and South Africa
  • systemic arthritis is more common in Asia
  • enthesitis-related arthritis incidence is greater in India, Mexico, and Canada

Reference:

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.